Low-force electronic bidet,
does it really help with Noninferior relief of pain seven days after hemorrhoidectomy as a substitute for a warm sitz bath?
research showsThe grade is D. BIDLOW used an active comparator—an approximately 38-degree-C warm sitz bath—not no treatment. Day-7 post-use pain VAS was 38.3+/-21.9 with the bidet versus 42.0+/-21.1 with sitz bath, P=.453, but prespecified noninferiority was not demonstrated. A nonsignificant difference is not proof that the bidet works as well as a sitz bath.
ads claimKorea's widespread bidet use makes replacement of sitz baths a practical question. The tested device was a purpose-built very-low-force fountain system, not ordinary high-pressure washing. Postoperative wound and bleeding instructions from the surgeon take priority.
Useful facts when choosing a product
- Both groups used approximately 38-degree-C water for 3-5 minutes each morning for seven days, with optional additional use for four weeks.
- The comparator was active warm sitz bathing, with no untreated arm.
- The tested Coway Clinic Bidet used a lower-force fountain stream than commercial electronic bidets.
Chamgap Semantic Classification Code
Candidate index · review held
P.very-low-force-fountain-type-electronic-bidet-using-approximately-38-degree-c-water.procedural.relief-of-pain-after-hemorrhoidectomy-as-a-substitute-for-a-warm-sitz-bath.noninferior.activeProcedures, devices and tests > very-low-force fountain-type electronic bidet using approximately 38-degree-C water > Procedural > relief of pain after hemorrhoidectomy as a substitute for a warm sitz bath > Noninferiority claim > Active comparator
An automated migration candidate, not an issued permanent code; exact claim scope remains under review. This machine-generated migration candidate helps retrieval but is not a permanent assignment. The original verdict ID and URL remain authoritative.
What the research actually shows
Four hospitals used an independent web randomization system and kept surgeons blinded. Participant blinding was inherently impractical and was not counted by itself. Three avoidable defects remained: a noninferiority design, fewer than 200 participants, and 25.7% post-randomization loss. Coway supported the study through the SNUH Clinical Research Institute and provided material and technical support; the principal investigator and Coway R&D jointly developed and patented the device.
Why this is classified as D (28)
A single manufacturer-supported noninferiority trial missed its main hypothesis and also had a small sample and 25.7% attrition, giving D with 28 points. Its margin came from applying 10% to the observed control mean and was not a patient-anchor-validated minimum clinically important difference.
Counterpoint. Wound healing was similar and convenience higher, but neither establishes pain noninferiority.
Rejudgment record. Cross-check applied — Failed active-control noninferiority primary endpoint in a manufacturer-supported small trial with substantial attrition
| Endpoint | P | Symptom or function itself is the target - including patient reports and performance tests |
| Replication | R1 | Single confirmatory trial |
| Independence | I0 | Evidence comes only from manufacturer studies |
| Effect size | E0 | Null |
| Precision | C0 | The confidence interval leaves room for benefit |
Stored derived and displayed grades match; this is not a current recalculation or validity check (D).
Sub-claim grades by effect
This ingredient is marketed for several effects. A single overall grade blends strong and weak claims together, so each effect is graded separately here. The overall grade reflects the strongest disconfirming or core claim.
| Effect (sub-claim) | Grade | Basis |
|---|---|---|
| Noninferior day-7 pain relief versus warm sitz bath | D | Means were similar, but the prespecified noninferiority test failed. |
| Wound healing at four weeks | C | Rates were 97.1% versus 97.6%, a secondary endpoint in a small trial. |
| Convenience of postoperative care | C | Convenience was higher with the bidet, 85.3% versus 56.1%. |
Cross-check — AI research and Codex final gate
Evidence Table
| Study | Design | Sample | Funding | Endpoint | Result | Weight |
|---|---|---|---|---|---|---|
| Kwon YH et al. 2025 BIDLOW | Multicenter single-blind randomized active-control noninferiority trial | 101 randomized, 51/50; 75 in the main analysis, 34/41 | Coway Co. Korea grant and material/technical support; SNU College of Medicine Research Foundation grant | Primary: post-use pain VAS on day 7; secondary: four-week wound healing and convenience | VAS 38.3+/-21.9 versus 42.0+/-21.1, P=.453; noninferiority not demonstrated | Only direct bidet-versus-sitz-bath RCT |
Receipt — 2 References
All 2 cited sources were verified for existence at the original page (as of 2026-08-07).
Final verification and publication gate: Codex · Evidence date: 2026-08-07 · Corrections: none
Cite this verdict
[Chamgap] Low-force electronic bidet x pain relief after hemorrhoidectomy — Evidence Grade D·28. 2 cited sources checked. Source: https://chamgap.com/en/verdicts/general/low-force-electronic-bidet-vs-sitz-bath-posthemorrhoidectomy-pain/ · CC BY 4.0CC BY 4.0 — free to use with attribution; do not distort grades, numbers, or verdict meaning.
What this document does and does not do
Chamgap is an information source. It reports what research has and has not confirmed; it does not tell readers what to take or buy. That decision belongs to readers and, when needed, medical or legal professionals. This verdict reflects literature available up to the search date and may change as new research appears. Nothing here is medical advice.